Roger Badia Córcoles
Roger Badia is a Miguel Servet I associate researcher (Instituto de Salud Carlos III, Ministry of Science, Innovation and Universities). He holds a PhD in Immunology from the Institute of Biotechnology and Biomedicine at the Autonomous University of Barcelona (IBB-UAB). His research focuses on the molecular mechanisms underlying host-pathogen interaction. Genome editing using CRISPR-Cas9 is the day-to-day toolbox he uses to study cellular cofactors and restriction factors implicated in the HIV replication cycle. Outside the lab he enjoys playing with his daughters, having fun with the guitar, playing rugby and being with his friends.
Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response.
Pharmacological Inhibition of IKK to Tackle Latency and Hyperinflammation in Chronic HIV-1 Infection.
Viral-Host Dependency Factors as Therapeutic Targets to Overcome Antiviral Drug-Resistance: A Focus on Innate Immune Modulation
IRF7 expression correlates with HIV latency reversal upon specific blockade of immune activation.
Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.